Fused pyrimidine derivatives for inhibition of tyrosine kinase activity
US8957065B2 · kind B2 · utility
10Cited by
0References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 20, 2011 |
| Grant date | Feb 17, 2015 |
| Priority date | — |
| Expiry date | Feb 4, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6561
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel fused pyrimidine derivative having an inhibitory activity for tyrosine kinases, and a pharmaceutical composition for preventing or treating cancers, tumors, inflammatory diseases, autoimmune diseases, or immunologically mediated diseases comprising same as an active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.